Tome Biosciences
@Tome_bio
Followers
353
Following
1
Media
19
Statuses
34
Explore trending content on Musk Viewer
Rafah
• 570615 Tweets
GW最終日
• 359443 Tweets
連休最終日
• 113922 Tweets
井上尚弥
• 80361 Tweets
ゴールデンウィーク最終日
• 67331 Tweets
#GOAT_50Mviews
• 58489 Tweets
GW最後
• 46146 Tweets
ゴムの日
• 31625 Tweets
スタメン
• 30323 Tweets
#岸辺露伴ルーヴルへ行く
• 30048 Tweets
ボクシング
• 23642 Tweets
PRABOWOajak SEMUAkompak
• 22505 Tweets
KarenaKITA SatuBANGSA
• 21891 Tweets
シェリン
• 18929 Tweets
Happy New Week
• 17650 Tweets
名古屋グランプリ
• 16816 Tweets
大千秋楽
• 12339 Tweets
I MISS YOU GULF
• 11235 Tweets
Tome Biosciences emerges from stealth with $200M+ Series B funding to advance genetic medicine with the ability to insert large DNA segments wherever they’re programmed to go.
Read the press release here:
#TomeBio
#CRISPR
#LastChapterofGenomicMedicine
0
12
50
Today, Tome acquired Replace Therapeutics Inc., a private
#biotechnology
company developing a novel PGI method capable of inserting and deleting small
#DNA
sequences.
Learn how this technology complements Tome’s integrase-mediated PGI (I-PGI):
#CRISPR
2
6
20
Tome’s President and CEO, Dr. Rahul Kakkar, joined
@acremades
on the Dealmakers podcast. Dr. Kakkar spoke about his professional journey in
#biotech
, including the importance of colleague support and how fatherhood shaped his broader perspective.
1
2
9
Tome’s CEO, Rahul Kakkar, sat down with
@TheralDTimpson
of
@mendelspod
to discuss how genomic-based therapies are crucial in curing diseases versus treating them.
#CRISPR
#genomeediting
#TomeBio
#genomicmedicine
0
6
9
Tome is proud to announce the formation of its Science and Technology Advisory Committee (STAC) made up of four instrumental leaders in the delivery, development, and manufacturing of genomic medicines.
Learn more here:
0
0
6
#TomeBio
President and CEO Dr. Rahul Kakkar was a guest on
@GlobalGenes
' RAREcast with
@dslevine
, discussing Tome’s potential to revolutionize cell and gene therapies, offering hope for the millions living with
#rarediseases
worldwide.
0
2
6
Happy
#InternationalDayOfWomenAndGirlsInScience
!
Women profoundly impact research and innovation and are invaluable as we pursue cures for a lifetime. Today, we’re highlighting a few of our very own who are paving the way for a more inclusive and diverse future.
#WomenInSTEM
0
1
5
At Tome, giving back is in our DNA. This holiday season, we joined the
@Mass_DCF
’s Wonderfund Holiday Drive, proudly sponsoring gifts for 50 children in the Watertown and Waltham communities.
#TomeBio
#communityservice
0
1
5
Happy
#EmployeeAppreciationDay
!
As a small token of appreciation, we hosted a breakfast for our employees to honor their commitment and hard work.
With their insightful ideas and unwavering commitment, our team is the driving force behind our success.
0
0
4
#RareDiseaseDay
is a time of unity and support for individuals & families living with rare diseases.
With the help of technology, like PGI, we can impact the rare disease community. Let's all work together to improve the lives of those affected.
#RareDiseases
#GeneEditing
0
1
6
Last year was a pivotal year, and we're immensely proud of our team's exceptional achievements. We'd like to recognize their dedication and growth, and exemplary demonstration of Tome's core values.
With our team here at Tome, our work and progress are possible.
#TomeBio
0
0
4
Thank you to
@RLCscienceboss
from
@endpts
for the interview. Tome’s recent acquisition of Replace Therapeutics strengthens our mission of bringing potentially curative PGI solutions to patients through cell and integrative gene therapies.
#celltherapy
#genetherapy
0
0
2
The FDA recently approved Casgevy, a CRISPR therapeutic for beta-thalassemia. Congrats to
@VertexPharma
and
@CRISPRTX
on this important milestone in genomic editing treatments.
#CRISPR
0
0
2
@NaturePortfolio
covers some exciting ideas on how to take
#CRISPR
to the next level in this article.
However, inserting large DNA segments remains a challenge among these "CRISPR 2.0" techniques.
0
0
1
We are excited to welcome Daniel Curran, MD, to Tome’s Board of Directors and look forward to the valuable corporate and drug development expertise he will bring to Tome.
#TomeBio
#CellandGeneTherapy
0
1
1
More exciting news about our recent emergence from stealth!
We appreciate the shout-out,
@BosBizJournal
. Thank you for sharing our story about revolutionizing genetic medicine with programmable genomic integration.
#TomeBio
0
0
1